Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Amati

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Seminars in Respiratory and Critical Care Medicine|July 7, 2020
Emerging Resistance of Gram Negative Pathogens in Community-Acquired PneumoniaFrancesco Amati, Marcos I Restrepo
Biomedicines|July 29, 2025
Endotypes and Phenotypes in ILD: Is It Time to Reclassify ILD by Risk Stratification?Francesco Amati, Anna Stainer, Stefano Aliberti
Chest|May 9, 2021
One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19Francesco Amati, Charles S Dela Cruz
Respiratory Research|March 6, 2024
Response to: are there over 200 distinct types of interstitial lung diseases?Francesco Amati, Anna Stainer, Stefano Aliberti
Biomedicines|October 29, 2025
Beyond Labels: Can Biomarkers and Treatable Traits Revolutionize Interstitial Lung Disease Care?Francesco Amati, Anna Stainer, Stefano Aliberti
Seminars in Respiratory and Critical Care Medicine|January 16, 2023
Glucocorticoid Therapy in COVID-19Francesco Amati, Antonio Tonutti, John Huston, et al.
Microorganisms|November 11, 2022
Cardiovascular Complications in Community-Acquired PneumoniaAntonio Desai, Stefano Aliberti, Francesco Amati, et al.
Respiration; International Review of Thoracic Diseases|January 23, 2017
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look ForFrancesco Amati, Elisa Franceschi, Andrea Gramegna, et al.
Lancet (London, England)|September 5, 2021
Community-acquired pneumoniaStefano Aliberti, Charles S Dela Cruz, Francesco Amati, et al.
Clinics in Chest Medicine|May 27, 2026
Global Variation in Pneumonia EpidemiologyMargherita S Silani, Anna Stainer, Francesco Amati, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Seminars in Respiratory and Critical Care Medicine|July 7, 2020
Emerging Resistance of Gram Negative Pathogens in Community-Acquired PneumoniaFrancesco Amati, Marcos I Restrepo
Biomedicines|July 29, 2025
Endotypes and Phenotypes in ILD: Is It Time to Reclassify ILD by Risk Stratification?Francesco Amati, Anna Stainer, Stefano Aliberti
Chest|May 9, 2021
One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19Francesco Amati, Charles S Dela Cruz
Respiratory Research|March 6, 2024
Response to: are there over 200 distinct types of interstitial lung diseases?Francesco Amati, Anna Stainer, Stefano Aliberti
Biomedicines|October 29, 2025
Beyond Labels: Can Biomarkers and Treatable Traits Revolutionize Interstitial Lung Disease Care?Francesco Amati, Anna Stainer, Stefano Aliberti
Seminars in Respiratory and Critical Care Medicine|January 16, 2023
Glucocorticoid Therapy in COVID-19Francesco Amati, Antonio Tonutti, John Huston, et al.
Microorganisms|November 11, 2022
Cardiovascular Complications in Community-Acquired PneumoniaAntonio Desai, Stefano Aliberti, Francesco Amati, et al.
Respiration; International Review of Thoracic Diseases|January 23, 2017
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look ForFrancesco Amati, Elisa Franceschi, Andrea Gramegna, et al.
Lancet (London, England)|September 5, 2021
Community-acquired pneumoniaStefano Aliberti, Charles S Dela Cruz, Francesco Amati, et al.
Clinics in Chest Medicine|May 27, 2026
Global Variation in Pneumonia EpidemiologyMargherita S Silani, Anna Stainer, Francesco Amati, et al.
Pageof 7